Article
Psychology, Clinical
Juliana Corlier, Reza Tadayonnejad, Andrew C. Wilson, Jonathan C. Lee, Katharine G. Marder, Nathaniel D. Ginder, Scott A. Wilke, Jennifer Levitt, David Krantz, Andrew F. Leuchter
Summary: This study aimed to investigate whether pain symptoms in MDD patients are associated with a poorer response to rTMS treatment. The results showed that both depressive and pain symptoms significantly reduced after rTMS treatment, irrespective of age or gender. However, patients with chronic pain symptoms were less likely to respond to MDD treatment.
PSYCHOLOGICAL MEDICINE
(2023)
Article
Medicine, Research & Experimental
Katharina M. Steiner, Dagmar Timmann, Ulrike Bingel, Angelika Kunkel, Tamas Spisak, Manfred Schedlowski, Sven Benson, Harald Engler, Norbert Scherbaum, Katja Koelkebeck
Summary: This study aims to investigate the expectation effects of repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder (MDD), and to expand the potential of non-invasive and well-tolerated treatments for MDD by analyzing the underlying mechanisms.
Article
Medicine, General & Internal
Seong Hoon Bae, Seo Jin Moon, Jeong Gum Lee, Yun Kyung Yim, Hee So Oh, Dong Hee Han, In Seok Moon
Summary: The study compared the effects of rTMS and tDCS treatments for chronic tinnitus, showing comparable results in reducing tinnitus symptoms, with tDCS possibly being more cost-effective.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Engineering, Biomedical
Behrouz Nobakhsh, Ahmad Shalbaf, Reza Rostami, Reza Kazemi, Erfan Rezaei, Reza Shalbaf
Summary: This study aims to predict the treatment response of Major depressive disorder (MDD) patients to repetitive transcranial magnetic stimulation (rTMS) using machine learning approaches. By analyzing the electroencephalogram (EEG) signals before treatment, the study identifies a significant brain biomarker in the delta and theta frequency bands that can accurately assess the treatment response. The proposed method shows high accuracy and can avoid financial and time costs for both patients and medical centers.
PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE
(2023)
Article
Psychiatry
Robert Gyorgy Vida, Eszter Saghy, Richard Bella, Sandor Kovacs, Dalma Erdosi, Judit Jozwiak-Hagymasy, Antal Zemplenyi, Tamas Tenyi, Peter Osvath, Viktor Voros
Summary: A systematic literature review found that unilateral High-Frequency Left-sided (HFL) repetitive Transcranial Magnetic Stimulation (rTMS) was more effective than sham rTMS in treating Treatment-Resistant Depression (TRD). rTMS may be beneficial as an adjunctive treatment in patients with Major Depressive Disorder (MDD) after two treatment failures.
Article
Psychology, Clinical
Alex M. Mirman, Juliana Corlier, Andrew C. Wilson, Reza Tadayonnejad, Katharine G. Marder, Christopher M. Pleman, David E. Krantz, Scott A. Wilke, Jennifer G. Levitt, Nathaniel D. Ginder, Rashi Ojha, Zafiris J. Daskalakis, Andrew F. Leuchter, Jonathan C. Lee
Summary: This study evaluated early changes in sleep, anxiety, and mood as predictors of nonresponse to repetitive transcranial magnetic stimulation (rTMS) treatment. The lack of early mood improvement was identified as a practical method to predict nonresponse, indicating a need for treatment protocol change in patients with severe baseline depression and minimal early mood improvement.
DEPRESSION AND ANXIETY
(2022)
Article
Psychiatry
Ronald E. See, Branon Eusebio, David Agnew, Mark Heatwole
Summary: The study found that steroid hormones may not be reliable biomarkers of treatment response in patients with major depressive disorder undergoing repetitive transcranial magnetic stimulation (rTMS). While rTMS significantly improved symptoms, salivary biomarker levels did not show significant changes during the treatment sessions.
PSYCHIATRY RESEARCH
(2021)
Article
Clinical Neurology
Lipeng Ning, Yogesh Rathi, Tracy Barbour, Nikos Makris, Joan A. Camprodon
Summary: This study utilized novel dMRI analysis to investigate microstructural changes related to rTMS treatment response in 21 MDD patients, finding that rTMS significantly affected the white matter microstructure in the anterior-medial prefrontal fiber bundles, while changes in lateral prefrontal tracts were correlated with treatment response. Further research with larger datasets is needed to fully understand the impact of rTMS on structural connectivity in MDD patients.
JOURNAL OF AFFECTIVE DISORDERS
(2022)
Article
Psychology, Clinical
Scott A. Wilke, Crystal L. Johnson, Juliana Corlier, Katharine G. Marder, Andrew C. Wilson, Christopher M. Pleman, Andrew F. Leuchter
Summary: MDD patients taking psychostimulant medication show greater clinical improvement during rTMS treatment, particularly in sleep and mood/cognition. There are no significant differences among different drug categories, and the clinical efficacy of some medications may be dose-dependent.
DEPRESSION AND ANXIETY
(2022)
Article
Psychiatry
Reza Tadayonnejad, Andrew C. Wilson, Stephanie Anne Chu, Juliana Corlier, Cole Citrenbaum, Thuc Doan P. Ngo, Emmily Hovhannisyan, Nathaniel D. Ginder, Jennifer G. Levitt, Scott A. Wilke, David Krantz, Ausaf A. Bari, Andrew F. Leuchter
Summary: This study examined the safety and efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) of the right orbi-tofrontal cortex (OFC) in patients with refractory obsessive-compulsive disorder (OCD) and comorbid Major Depressive Disorder. The results showed that the augmentation with OFC stimulation was well-tolerated and associated with further alleviation of symptoms in both OCD and depression, especially in individuals with more severe illnesses.
PSYCHIATRY RESEARCH
(2022)
Article
Clinical Neurology
Andrew F. Leuchter, Andrew C. Wilson, Nikita Vince-Cruz, Juliana Corlier
Summary: The study identified a correlation between 10 Hz stimulation resonance measured using SCC and both symptom severity and improvement with 10 Hz rTMS treatment. Decreased SCC SM resonance was significantly associated with clinical improvement after 10 sessions of rTMS treatment.
Review
Clinical Neurology
Mohamed Abo Aoun, Benjamin P. Meek, Luc Clair, Sara Wikstrom, Benjamin Prasad, Mandana Modirrousta
Summary: This retrospective study investigated the predictive factors for patients receiving repetitive transcranial magnetic stimulation (rTMS) for major depressive disorder (MDD). The study found that Ham-D scores at 10 sessions and Sheehan Disability Scale (SDS) scores at 10 sessions were predictive of remission and response to rTMS. High frequency rTMS showed similar response and remission rates to low frequency, but had a higher response rate to intermittent Theta Burst Stimulation. Younger age and bupropion use were positive predictors of response, while antipsychotics, anticonvulsants, or benzodiazepine use were negative predictors. Antipsychotic or anticonvulsant use were negative predictors of remission, while bupropion use and higher resting motor threshold were positive predictors. Severity of depression measured by baseline HamD was not associated with treatment success.
PSYCHIATRY AND CLINICAL NEUROSCIENCES
(2023)
Article
Psychiatry
Stephanie A. Chu, Reza Tadayonnejad, Juliana Corlier, Andrew C. Wilson, Cole Citrenbaum, Andrew F. Leuchter
Summary: Rumination is a common symptom of Major Depressive Disorder (MDD) and is associated with poorer treatment outcomes. This study aimed to investigate the impact of rumination on repetitive Transcranial Magnetic Stimulation (rTMS) treatment of MDD. The data from 155 patients with treatment-resistant MDD were analyzed, and it was found that rTMS treatment improved both depression and rumination symptoms, although improvement in rumination was not fully explained by reduction in depressive symptoms. The findings suggest that rumination should be specifically targeted with different rTMS treatment parameters.
TRANSLATIONAL PSYCHIATRY
(2023)
Article
Psychiatry
Michael K. Leuchter, Cole Citrenbaum, Andrew C. Wilson, Tristan D. Tibbe, Nicholas J. Jackson, David E. Krantz, Scott A. Wilke, Juliana Corlier, Thomas B. Strouse, Gil D. Hoftman, Reza Tadayonnejad, Ralph J. Koek, Aaron R. Slan, Nathaniel D. Ginder, Margaret G. Distler, Hewa Artin, John H. Lee, Adesewa E. Adelekun, Andrew F. Leuchter
Summary: Clinical outcomes of repetitive Transcranial Magnetic Stimulation (rTMS) for treatment of Major Depressive Disorder (MDD) vary widely, and no single mood rating scale is standard for assessing rTMS outcomes. This study compared the performance of four scales in measuring symptom change during rTMS treatment. The results showed that all scales were correlated and detected significant improvement, but the degree of improvement, response rates, and remission rates varied significantly. Higher baseline severity was associated with lower likelihood of remission, and greater improvement by sessions 5 and 10 predicted response across all scales.
PSYCHIATRY RESEARCH
(2023)
Article
Clinical Neurology
Yu-Ting Hu, Xi-Wen Hu, Jin-Fang Han, Jian-Feng Zhang, Ying-Ying Wang, Annemarie Wolff, Sara Tremblay, Dusan Hirjak, Zhong-Lin Tan, Georg Northoff
Summary: This study compared the therapeutic efficacy of rTMS at the left motor cortex (lMC) and left dorsolateral prefrontal cortex (lDLPFC) in MDD patients. The results showed no significant difference in treatment outcomes and tolerability between the two groups. The findings suggest that lMC can be a potential and easily accessible rTMS target.
JOURNAL OF AFFECTIVE DISORDERS
(2024)
Article
Neurosciences
Juliana Corlier, Andrew Wilson, Aimee M. Hunter, Nikita Vince-Cruz, David Krantz, Jennifer Levitt, Michael J. Minzenberg, Nathaniel Ginder, Ian A. Cook, Andrew F. Leuchter
Article
Clinical Neurology
Andrew F. Leuchter, Andrew C. Wilson, Nikita Vince-Cruz, Juliana Corlier
Summary: The study identified a correlation between 10 Hz stimulation resonance measured using SCC and both symptom severity and improvement with 10 Hz rTMS treatment. Decreased SCC SM resonance was significantly associated with clinical improvement after 10 sessions of rTMS treatment.
Article
Psychology, Clinical
Juliana Corlier, Reza Tadayonnejad, Andrew C. Wilson, Jonathan C. Lee, Katharine G. Marder, Nathaniel D. Ginder, Scott A. Wilke, Jennifer Levitt, David Krantz, Andrew F. Leuchter
Summary: This study aimed to investigate whether pain symptoms in MDD patients are associated with a poorer response to rTMS treatment. The results showed that both depressive and pain symptoms significantly reduced after rTMS treatment, irrespective of age or gender. However, patients with chronic pain symptoms were less likely to respond to MDD treatment.
PSYCHOLOGICAL MEDICINE
(2023)